Loading
SEC Form 13F · Q2 2026
Hillman Capital Mgmt portfolio
Mark Hillman · Hillman Capital Management, Inc. · CIK 0001314620
Latest 13F for the quarter ended Jun 30, 2026, filed Aug 14, 2026, compared with the quarter ended Mar 31, 2026.
Reported 13F value$138.2M
Holdings54
Top 10 concentration36.3%
New positions3
Added to14
Reduced35
Closed5
What changed in Q2 2026
Estimated trade value from reported units and period-end values
New positions
Added to
Reduced
Closed
Holdings, Q2 2026
54 positions by reported value
| Holding | Portfolio weight | Reported value | Shares / units | Change vs prior quarter |
|---|---|---|---|---|
| CVSCVS HEALTH CORP · COM | 4.15% | $5.7M | 55,475 | -17.8% |
| BIIBBIOGEN INC · COM | 3.75% | $5.2M | 23,993 | -18.8% |
| 26614N201DUPONT DE NEMOURS INC · COMMON STOCK | 3.71% | $5.1M | 37,745 | New |
| WBDWARNER BROS DISCOVERY INC · COM SER A | 3.67% | $5.1M | 189,986 | -3.2% |
| BAXBAXTER INTL INC · COM | 3.64% | $5.0M | 236,032 |
Source: SEC Form 13F filings (latest filing on sec.gov). Information and analytics, not investment advice. Holdings are reported as of the quarter end, not live positions; reported 13F value covers securities listed on Form 13F and is not the fund's total assets under management.